Clinical Nutrition Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Clinical Nutrition Market is Segmented by Route of Administration (Oral and Enteral, and More), Product Type (Infant Nutrition, and More), Form (Powder and More), Application (Nutritional Support for Malnutrition, and More), by End User (Pediatric, and More), Distribution Channel (Hospital Pharmacies, and More), and Geography (North America, Europe, and More). The Market Sizes and Forecasts are Provided in Terms of Value (USD).

Clinical Nutrition Market Size and Share

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Compare market size and growth of Clinical Nutrition Market with other markets in Healthcare Industry

Clinical Nutrition Market Analysis by Mordor Intelligence

The clinical nutrition market size is estimated at USD 78.11 billion in 2025 and is expected to reach USD 115.03 billion by 2030, reflecting an 8.05 % CAGR during the forecast period (2025-2030). The rising prevalence of metabolic disorders like diabetes and dysphagia is boosting the clinical nutrition market. These specialized formulations meet the growing need for essential nutrients, aiding recovery and improving health outcomes. The geriatric segment is intersecting with the rapid expansion of clinical nutrition use in oncology. As cancer cases rise, the inclusion of dietitians in pre-admission planning becomes essential, as specialized formulas are gaining importance in multidisciplinary treatment pathways. This shift creates more opportunities for the manufacturers operating in the clinical nutrition market.  

Key Report Takeaways

  • By route of administration, enteral nutrition captured 69.6% of the clinical nutrition market share in 2024, while parenteral nutrition is projected to expand at an 8.5% CAGR through 2030.
  • By product type, infant nutrition products led with a 44.6% share in 2024; disease-specific enteral formulas are forecast to advance at a 9.1% CAGR to 2030.
  • By form, liquid formulations accounted for 60.3% of 2024 revenue, and semi-solid products are growing at an 8.6% CAGR through 2030.
  • By application, malnutrition support represented 31.0% of the market size in 2024, whereas cancer-related nutrition solutions show the fastest momentum with a 9.1% CAGR during 2025-2030.
  • By end user, adults constituted 50.6% of demand in 2024, and the geriatric segment is expected to rise at a 9.3% CAGR to 2030.
  • By distribution channel, hospital pharmacies controlled 57.0% of sales in 2024, while online pharmacies are set to post a 10.1% CAGR through 2030.
  • By geography, North America captured 34.8% of the contrast media market share in 2024, whereas Asia-Pacific holds the strongest growth outlook with 8.3% CAGR through 2030. 

Segment Analysis

Enteral Dominates While Parenteral Accelerates

Oral and enteral nutrition commands 69.6% of the clinical nutrition market in 2024, reflecting its established position as the preferred administration route when the gastrointestinal tract remains functional. Meanwhile, parenteral nutrition is projected to grow at a faster rate of 8.5% CAGR during 2025-2030, driven by expanding applications in critical care and oncology settings. The parenteral segment's growth is further accelerated by innovations in lipid emulsions, particularly the integration of fish oil rich in omega-3 fatty acids, which has demonstrated clinical benefits, including reduced infection rates and shorter hospital stays in critically ill patients.

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Infant Nutrition Leads While Disease-Specific Formulas Surge

In 2024, infant nutrition products held a 44.6% market share. However, disease-specific enteral formulas are projected to grow at a 9.1% CAGR through 2030. Government-led initiatives aimed at improving infant health and nutrition, such as funding for nutritional programs and guidelines for infant and child dietary needs, are significantly enhancing the availability and accessibility of nutritional formulations tailored for children. These efforts create awareness and promote compliance among caregivers, thereby driving market growth. For instance, in September 2023, the National Nutrition Council of the Philippines launched the Philippine Plan of Action for Nutrition (PPAN) 2023-2028. This strategic framework aims to combat stunting, childhood obesity, and malnutrition, driving the demand for clinical nutrition products. Such government support not only fosters innovation in clinical nutrition products tailored to combat malnutrition and obesity but also encourages investment from both public and private sectors, thereby expanding market opportunities.

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Liquid Formulations Maintain Dominance in the Market

In 2024, liquid formulations constituted 60.3% of the market. Their versatility with both enteral tubes and intravenous lines solidifies their leading position. Meanwhile, semi-solid products targeting dysphagia are set to grow at an annual rate of 8.6%. Suppliers are increasingly adopting a strategy of packaging high-calorie liquids in retort pouches. This innovation not only extends the ambient shelf life but also enables community pharmacies to maintain leaner safety stocks, potentially enhancing working capital metrics throughout the distribution chain.

Malnutrition Support Dominates While Cancer Care Accelerates

In 2024, malnutrition therapy accounted for 31.0% of applications. However, nutrition solutions tailored for cancer care are on track for a 9.1% CAGR. Oncology centers are now integrating specialized formulas into Enhanced Recovery After Surgery (ERAS) pathways. This collaboration positions nutrition companies as integral players in perioperative protocols, paving the way for cross-licensing deals with device firms that provide surgical staplers or wound-closure systems. Such partnerships could unveil additional revenue streams beyond just the nutritional formulas.

Adult Segment Leads While Geriatric Growth Accelerates

Adults made up 50.6% of demand in 2024 due to the increasing prevalence of chronic diseases among the adult population, which necessitates specialized nutritional support for different conditions like diabetes and cancer. Whereas the geriatric nutrition market is set to grow at an annual rate of 9.3%. Long-term-care operators are increasingly mandating high-leucine blends to combat sarcopenia. In response, suppliers are crafting lower-volume, higher-density drinks tailored for residents with reduced appetites. For about half of the surveyed nursing-home chains, geriatric-specific SKUs might account for nearly one-third of the overall nutrition spend by 2029, amplifying their bargaining power in supplier contracts.

Hospital Pharmacies Dominate While Online Channels Surge

In 2024, hospital pharmacies were responsible for 57.2% of clinical nutrition dispensation. Yet, online pharmacies are set to grow at a robust 10.1% CAGR, fueled by home-care discharges and an increasing consumer trust in telehealth. If current trends persist, online sales of medical nutrition could surpass 15% market share by 2030. This potential shift is prompting manufacturers to rethink packaging, emphasizing direct-to-patient shipping integrity over traditional palletized hospital deliveries.

Clinical Nutrition Market
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Geography Analysis

By Geography: Asia Pacific is Projected to Witness the Highest Growth

Chronic illnesses are a significant driver of the United States' staggering USD 4.5 trillion annual healthcare expenditure, accounting for nearly 90% of the total, as reported by the U.S. Centers for Disease Control and Prevention[2]Centers for Disease Control and Prevention, “Fast Facts: Health and Economic Costs of Chronic Conditions,” cdc.gov . In light of these figures, payer organizations are shifting their stance, increasingly opting to reimburse disease-specific nutrition formulas. These formulas not only address nutritional needs but also play a pivotal role in delaying more expensive medical interventions. 

According to the U.S. Centers for Disease Control and Prevention[3]Sharon L. Murphy, Kenneth D. Kochanek, Jiaquan Xu, Elizabeth Arias, “Mortality in the United States, 2023,” National Center for Health Statistics, cdc.gov, heart disease and stroke alone cost the U.S. healthcare system more than USD 250 billion annually, while diabetes imposes costs above USD 400 billion. As life expectancy climbed to 78.4 years in 2023, hospital groups intensified focus on sarcopenia and metabolic health, prompting suppliers to highlight amino-acid ratios and glycemic indices in product dossiers. For regional integrated-delivery networks, adult-diabetes formulations already account for a significant share of annual nutrition-therapy budgets, an allocation that re-prioritizes formulary reviews around metabolic metrics.

Europe stands as a sophisticated market for clinical nutrition, marked by stringent regulatory frameworks and well-established clinical practice guidelines. In March 2024, Germany launched several initiatives to enhance clinical nutrition as part of its "Good Food for Germany" strategy. This strategy, adopted by the Cabinet in January 2024, aims to improve the overall health and nutrition of the population. The German government's strategic implementation of comprehensive nutrition policies to combat malnutrition is anticipated to drive significant growth in the clinical nutrition market.

The Asia Pacific region is rapidly emerging as a lucrative market for clinical nutrition, spurred by increasing health awareness among consumers, driving demand for nutritional solutions that support overall well-being. Furthermore, government initiatives and policies promoting nutrition education and public health campaigns are fostering the adoption of healthier dietary practices. In May 2024, Fudan University School of Public Health highlighted the crucial role of food safety through a series of activities and educational programs. The initiative emphasized the importance of nutrition, particularly focusing on nutritional supplements for vulnerable populations such as the elderly and individuals with health issues. Additionally, in October 2024, the Union Health Minister (India) introduced key initiatives aimed at strengthening nutrition support for tuberculosis (TB) patients and their families. These initiatives focus on addressing the critical nutritional deficiencies often experienced by TB patients, which can hinder recovery and exacerbate health complications. By providing targeted nutritional interventions, these measures aim to enhance patient recovery rates, improve treatment adherence, and reduce the overall burden of the disease.

Clinical Nutrition Market
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Competitive Landscape

The market remains moderately concentrated around Abbott Laboratories, Nestlé Health Science, Fresenius Kabi, and Baxter International. These incumbents use a global scale to absorb compliance costs and to fund multi-country post-marketing studies that smaller firms cannot afford. 

Niche players such as Kate Farms and Ajinomoto Cambrooke differentiate through plant-based or rare metabolic-disorder portfolios, positioning themselves as takeover targets for strategics seeking depth in high-growth micro-segments. Recent M&A activity signals that buyers value platform technologies, such as adaptive lipid emulsions or modular packaging, over simple geographic reach, indicating a strategic pivot toward scientific depth.

Technological differentiation is becoming a game changer. Suppliers embed RFID or QR codes into packaging to integrate with hospital inventory systems, and some offer clinician dashboards that correlate nutrient delivery with lab results. This integration elevates nutrition vendors from commodity suppliers to data partners, increasing switching costs and fortifying pricing power during tender renewals.

Clinical Nutrition Industry Leaders

  1. Abbott Laboratories

  2. Nestlé Health Science

  3. Fresenius Kabi

  4. Danone (Nutricia)

  5. Baxter International

  6. *Disclaimer: Major Players sorted in no particular order
Clinical Nutrition Market
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • April 2025: Abbott Laboratories launched a new immunonutrition formula specifically designed for oncology patients undergoing chemotherapy, incorporating a proprietary blend of arginine, omega-3 fatty acids, and nucleotides to support immune function during treatment.
  • March 2025: Nestlé Health Science completed the acquisition of a specialized pediatric nutrition company for USD 1.2 billion, expanding its portfolio of products for children with rare metabolic disorders.
  • February 2025: Fresenius Kabi received FDA approval for a next-generation parenteral nutrition solution featuring an improved lipid emulsion with enhanced stability and reduced inflammatory potential.
  • January 2025: Baxter International announced a USD 500 million investment to expand its clinical nutrition manufacturing capacity in Asia Pacific, targeting growing demand in China and India.
  • December 2024: Danone (Nutricia) launched a comprehensive digital platform for healthcare professionals to monitor patients on home enteral nutrition, featuring remote adjustment capabilities and integration with electronic health records.

Table of Contents for Clinical Nutrition Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rapid Shift Toward Home-Based Enteral Feeding in Post-Acute Care
    • 4.2.2 Increased Adoption of Immunonutrition Formulas for Post Surgery Recovery
    • 4.2.3 Government-Funded Pediatric Malnutrition Programs
    • 4.2.4 Increasing Prevalence of Chronic Disease
    • 4.2.5 Bundled-Payment Reimbursement Incentives for Early Parenteral Nutrition
    • 4.2.6 Integration of AI-Enabled Nutrient Dosing Platforms in ICU Pharmacies
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Requirements and Lengthy Approval Processes
    • 4.3.2 Limited Insurance Coverage for Out-of-Hospital Parenteral Nutrition
    • 4.3.3 Frequent Supply Shortages of Sterile Lipid Emulsions
    • 4.3.4 Rising Raw-Material Prices for Medical-Grade Maltodextrin
  • 4.4 Value Chain Analysis
  • 4.5 Regulatory Outlook
  • 4.6 Technological Outlook
  • 4.7 Porter's Five Forces Analysis
    • 4.7.1 Threat of New Entrants
    • 4.7.2 Bargaining Power of Buyers
    • 4.7.3 Bargaining Power of Suppliers
    • 4.7.4 Threat of Substitutes
    • 4.7.5 Competitive Rivalry
  • 4.8 Clinical Trial Landscape

5. Market Size & Growth Forecasts (Value)

  • 5.1 By Route of Administration
    • 5.1.1 Oral & Enteral
    • 5.1.2 Parenteral
  • 5.2 By Product Type
    • 5.2.1 Infant Nutrition
    • 5.2.2 Standard Enteral Formula
    • 5.2.3 Disease-Specific Enteral Formula
    • 5.2.4 Total Parenteral Nutrition (TPN) Components
  • 5.3 By Form
    • 5.3.1 Powder
    • 5.3.2 Liquid
    • 5.3.3 Semi-Solid
  • 5.4 By Application
    • 5.4.1 Nutritional Support for Malnutrition
    • 5.4.2 Metabolic Disorders
    • 5.4.3 Gastrointestinal Diseases
    • 5.4.4 Cancer
    • 5.4.5 Neurological Diseases
    • 5.4.6 Other Diseases
  • 5.5 By End User
    • 5.5.1 Pediatric
    • 5.5.2 Adult
    • 5.5.3 Geriatric
  • 5.6 By Distribution Channel
    • 5.6.1 Hospital Pharmacies
    • 5.6.2 Retail Pharmacies
    • 5.6.3 Online Pharmacies
    • 5.6.4 Homecare & Specialty Clinics
  • 5.7 Geography
    • 5.7.1 North America
    • 5.7.1.1 United States
    • 5.7.1.2 Canada
    • 5.7.1.3 Mexico
    • 5.7.2 Europe
    • 5.7.2.1 Germany
    • 5.7.2.2 United Kingdom
    • 5.7.2.3 France
    • 5.7.2.4 Italy
    • 5.7.2.5 Spain
    • 5.7.2.6 Rest of Europe
    • 5.7.3 Asia Pacific
    • 5.7.3.1 China
    • 5.7.3.2 Japan
    • 5.7.3.3 India
    • 5.7.3.4 South Korea
    • 5.7.3.5 Australia
    • 5.7.3.6 Rest of Asia
    • 5.7.4 Middle East and Africa
    • 5.7.4.1 GCC
    • 5.7.4.2 South Africa
    • 5.7.4.3 Rest of Middle East and Africa
    • 5.7.5 South America
    • 5.7.5.1 Brazil
    • 5.7.5.2 Argentina
    • 5.7.5.3 Rest of South America

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
    • 6.3.1 Abbott Laboratories
    • 6.3.2 Nestle Health Science
    • 6.3.3 Fresenius Kabi
    • 6.3.4 Baxter International
    • 6.3.5 Danone (Nutricia)
    • 6.3.6 B. Braun SE
    • 6.3.7 Perrigo Company
    • 6.3.8 Reckitt Benckiser Group
    • 6.3.9 Ajinomoto Cambrooke
    • 6.3.10 AYMES International
    • 6.3.11 Medifood International
    • 6.3.12 Kate Farms

7. Market Opportunities & Future Outlook

  • 7.1 White-Space & Unmet-Need Assessment
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Global Clinical Nutrition Market Report Scope

As per the scope, clinical malnutrition refers to a condition that can be treated with clinical intervention by using specialized nutrients that are considered proper medications rather than as supplements. Clinical nutrition products are useful in maintaining the patient's health and enable the improvement of the body's metabolic system by providing adequate supplements, such as minerals, vitamins, and other supplements. A higher number of premature births also demand advanced clinical nutrition.

The clinical nutrition market is segmented by route of administration (oral & enteral, and parenteral), product type (infant nutrition, standard enteral formula, disease-specific enteral formula, total parenteral nutrition (TPN) components), form (powder, liquid, and semi-solid), application (nutritional support in malnutrition, metabolic disorders, gastrointestinal diseases, neurological diseases, cancer, and other diseases), end user (pediatric, adult, and geriatric), distribution channel (hospital pharmacies, retail pharmacies, online pharmacies, and homecare & specialty clinics), and geography (North America, Europe, Asia Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments. The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Route of Administration Oral & Enteral
Parenteral
By Product Type Infant Nutrition
Standard Enteral Formula
Disease-Specific Enteral Formula
Total Parenteral Nutrition (TPN) Components
By Form Powder
Liquid
Semi-Solid
By Application Nutritional Support for Malnutrition
Metabolic Disorders
Gastrointestinal Diseases
Cancer
Neurological Diseases
Other Diseases
By End User Pediatric
Adult
Geriatric
By Distribution Channel Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Homecare & Specialty Clinics
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia Pacific China
Japan
India
South Korea
Australia
Rest of Asia
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
By Route of Administration
Oral & Enteral
Parenteral
By Product Type
Infant Nutrition
Standard Enteral Formula
Disease-Specific Enteral Formula
Total Parenteral Nutrition (TPN) Components
By Form
Powder
Liquid
Semi-Solid
By Application
Nutritional Support for Malnutrition
Metabolic Disorders
Gastrointestinal Diseases
Cancer
Neurological Diseases
Other Diseases
By End User
Pediatric
Adult
Geriatric
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Homecare & Specialty Clinics
Geography
North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia Pacific China
Japan
India
South Korea
Australia
Rest of Asia
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

How big is the Clinical Nutrition Market?

The Clinical Nutrition Market size is expected to reach USD 78.11 billion in 2025 and grow at a CAGR of 8.05% to reach USD 115.03 billion by 2030.

What is the current Clinical Nutrition Market size?

In 2025, the Clinical Nutrition Market size is expected to reach USD 78.11 billion.

Which is the fastest growing region in Clinical Nutrition Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Clinical Nutrition Market?

In 2025, the North America accounts for the largest market share in Clinical Nutrition Market.

What years does this Clinical Nutrition Market cover, and what was the market size in 2024?

In 2024, the Clinical Nutrition Market size was estimated at USD 71.82 billion. The report covers the Clinical Nutrition Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Clinical Nutrition Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Clinical Nutrition Market Report Snapshots